RXST · RxSight, Inc. · Executive Compensation
$4.82
-0.09 (-1.73%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$201.73M
Shares
41.59M
Volume · Oct 28
245.75K
Avg daily vol (3M)
790.68K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Ron Kurtz, M.D. | member of the Board | Resigned | 2026-07-15 |
| Ron Kurtz, M.D. | Chief Medical Officer | Appointed | 2026-07-15 |
| Aziz Mottiwala | Class II director | Appointed | 2026-07-15 |
| Aziz Mottiwala | President and Chief Executive Officer | Appointed | 2026-07-15 |
| Mark Wilterding | Chief Financial Officer (and principal financial and accounting officer) | Appointed | 2026-01-12 |
| Scott Gaines | Chief Customer Officer | Appointed | 2025-12-19 |
| Eric Weinberg | Chief Business Development Officer | Appointed | 2025-12-19 |
| Raymond W. Cohen | Class I director | Appointed | 2025-08-04 |
Leadership
- Aziz Mottiwala CEO, Board Member
- Ron Kurtz CEO, Board Member
- Mark Wilterding CFO
- Ilya Goldshleger COO
- Raymond W. Cohen Board Member
- Shweta Singh Maniar Board Member
- Tamara Fountain, M.D. Board Member
Key facts
CIK
1111485
CUSIP
78349D107
13F (30d)
17 filings
17 filers
Visit website
Investor relations